264 related articles for article (PubMed ID: 17336934)
21. The paraffin-embedded tissue blot detects PrP(Sc) early in the incubation time in prion diseases.
Schulz-Schaeffer WJ; Tschöke S; Kranefuss N; Dröse W; Hause-Reitner D; Giese A; Groschup MH; Kretzschmar HA
Am J Pathol; 2000 Jan; 156(1):51-6. PubMed ID: 10623653
[TBL] [Abstract][Full Text] [Related]
22. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding.
Saborio GP; Permanne B; Soto C
Nature; 2001 Jun; 411(6839):810-3. PubMed ID: 11459061
[TBL] [Abstract][Full Text] [Related]
23. Removal of exogenous (spiked) and endogenous prion infectivity from red cells with a new prototype of leukoreduction filter.
Sowemimo-Coker S; Kascsak R; Kim A; Andrade F; Pesci S; Kascsak R; Meeker C; Carp R; Brown P
Transfusion; 2005 Dec; 45(12):1839-44. PubMed ID: 16371036
[TBL] [Abstract][Full Text] [Related]
24. Preparation of soluble infectious samples from scrapie-infected brain: a new tool to study the clearance of transmissible spongiform encephalopathy agents during plasma fractionation.
Berardi VA; Cardone F; Valanzano A; Lu M; Pocchiari M
Transfusion; 2006 Apr; 46(4):652-8. PubMed ID: 16584444
[TBL] [Abstract][Full Text] [Related]
25. Infectivity of scrapie prion protein (PrPSc) following in vitro digestion with bovine gastrointestinal microbiota.
Scherbel C; Pichner R; Groschup MH; Mueller-Hellwig S; Scherer S; Dietrich R; Maertlbauer E; Gareis M
Zoonoses Public Health; 2007; 54(5):185-90. PubMed ID: 17542960
[TBL] [Abstract][Full Text] [Related]
26. Prion removal effect of a specific affinity ligand introduced into the manufacturing process of the pharmaceutical quality solvent/detergent (S/D)-treated plasma OctaplasLG.
Neisser-Svae A; Bailey A; Gregori L; Heger A; Jordan S; Behizad M; Reichl H; Römisch J; Svae TE
Vox Sang; 2009 Oct; 97(3):226-33. PubMed ID: 19548963
[TBL] [Abstract][Full Text] [Related]
27. Induced neuroprotection independently from PrPSc accumulation in a mouse model for prion disease treated with simvastatin.
Haviv Y; Avrahami D; Ovadia H; Ben-Hur T; Gabizon R; Sharon R
Arch Neurol; 2008 Jun; 65(6):762-75. PubMed ID: 18541796
[TBL] [Abstract][Full Text] [Related]
28. Development of oligomeric prion-protein aggregates in a mouse model of prion disease.
Sasaki K; Minaki H; Iwaki T
J Pathol; 2009 Sep; 219(1):123-30. PubMed ID: 19479969
[TBL] [Abstract][Full Text] [Related]
29. The propagation of hamster-adapted scrapie PrPSc can be enhanced by reduced pyridine nucleotide in vitro.
Shi S; Dong CF; Tian C; Zhou RM; Xu K; Zhang BY; Gao C; Han J; Dong XP
FEBS J; 2009 Mar; 276(6):1536-45. PubMed ID: 19220459
[TBL] [Abstract][Full Text] [Related]
30. The effect of Fenton reaction on protease-resistant prion protein (PrPSc) degradation and scrapie infectivity.
Park SJ; Kim NH; Jeong BH; Jin JK; Choi JK; Park YJ; Kim JI; Carp RI; Kim YS
Brain Res; 2008 Oct; 1238():172-80. PubMed ID: 18771660
[TBL] [Abstract][Full Text] [Related]
31. Characterization of a proteolytic enzyme derived from a Bacillus strain that effectively degrades prion protein.
Yoshioka M; Miwa T; Horii H; Takata M; Yokoyama T; Nishizawa K; Watanabe M; Shinagawa M; Murayama Y
J Appl Microbiol; 2007 Feb; 102(2):509-15. PubMed ID: 17241357
[TBL] [Abstract][Full Text] [Related]
32. Binding of disease-associated prion protein to plasminogen.
Fischer MB; Roeckl C; Parizek P; Schwarz HP; Aguzzi A
Nature; 2000 Nov; 408(6811):479-83. PubMed ID: 11100730
[TBL] [Abstract][Full Text] [Related]
33. Acetone precipitation of the scrapie agent results in successful recovery of PrP(Sc) but decreased infectivity.
Smith JD; Greenlee JJ; Foster GH; Nicholson EM
J Agric Food Chem; 2012 May; 60(18):4758-62. PubMed ID: 22519670
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms of prion disease progression: a chemical reaction network approach.
Méndez JM; Femat R
IET Syst Biol; 2011 Nov; 5(6):347-52. PubMed ID: 22129030
[TBL] [Abstract][Full Text] [Related]
35. Rapid assessment of bovine spongiform encephalopathy prion inactivation by heat treatment in yellow grease produced in the industrial manufacturing process of meat and bone meals.
Yoshioka M; Matsuura Y; Okada H; Shimozaki N; Yamamura T; Murayama Y; Yokoyama T; Mohri S
BMC Vet Res; 2013 Jul; 9():134. PubMed ID: 23835086
[TBL] [Abstract][Full Text] [Related]
36. The metabolism of glycosaminoglycans is impaired in prion diseases.
Mayer-Sonnenfeld T; Zeigler M; Halimi M; Dayan Y; Herzog C; Lasmezas CI; Gabizon R
Neurobiol Dis; 2005 Dec; 20(3):738-43. PubMed ID: 15951190
[TBL] [Abstract][Full Text] [Related]
37. Detection of prions in blood.
Castilla J; Saá P; Soto C
Nat Med; 2005 Sep; 11(9):982-5. PubMed ID: 16127436
[TBL] [Abstract][Full Text] [Related]
38. Plasminogen stimulates propagation of protease-resistant prion protein in vitro.
Mays CE; Ryou C
FASEB J; 2010 Dec; 24(12):5102-12. PubMed ID: 20732953
[TBL] [Abstract][Full Text] [Related]
39. Sulfated dextrans enhance in vitro amplification of bovine spongiform encephalopathy PrP(Sc) and enable ultrasensitive detection of bovine PrP(Sc).
Murayama Y; Yoshioka M; Masujin K; Okada H; Iwamaru Y; Imamura M; Matsuura Y; Fukuda S; Onoe S; Yokoyama T; Mohri S
PLoS One; 2010 Oct; 5(10):. PubMed ID: 20957174
[TBL] [Abstract][Full Text] [Related]
40. Reconstitution of prion infectivity from solubilized protease-resistant PrP and nonprotein components of prion rods.
Shaked GM; Meiner Z; Avraham I; Taraboulos A; Gabizon R
J Biol Chem; 2001 Apr; 276(17):14324-8. PubMed ID: 11152454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
